BMT and High Dose Post-Transplant Cyclophosphamide for Chimerism Induction and Renal Allograft Tolerance

(

ACCEPTOR

)

ITN Protocol #:

ITN054ST

Branded Name:

ACCEPTOR

ClinicalTrials.Gov ID:

NCT02029638

Treatment Protocol #:

Therapeutic Area:

Transplantation

Current Status:

Terminated

ITN Website Clinical Trial Recruiting Site Document Portal Location Study on ITN TrialShare

Summary:

Bone Marrow Transplantation and High Dose Post-Transplant Cyclophosphamide for Chimerism Induction and Renal Allograft Tolerance

Clinical Operations Manager

ITN Biologist

ITN Biostat

ITN Clinical Trial Physician

NIAID Project Manager

Rho Scientist

Study Personnel:

Protocol Chair

Lode Swinnen, MD lswinne1@jhmi.edu

Work:

410-614-6398

Protocol Chair

Michele DesMarais mdesmarais@immunetolerance.org

Work:

415-420-4250

Protocol Chair

Bryna Burrell bburrell@immunetolerance.org

Work:

240-235-6130

Protocol Chair

Sai Kanaparthi skanaparthi@immunetolerance.org

Work:

(240)235-6101

Protocol Chair

Peter Sayre psayre@immunetolerance.org

Work:

415-353-4423

Protocol Chair

Merideth Brown Shifflett brownmeri@niaid.nih.gov

Work:

240-627-3483

Protocol Chair

Heather A. Kopetskie Heather_Kopetskie@rhoworld.com

Work:

919-595-6475